Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.0K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

239
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
239
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

249
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
249
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.2K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

356
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
356

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval Study.

Circulation. Cardiovascular interventions·2026
Same author

Endovascular Treatment Modalities for Infrapopliteal Artery Disease: A Bayesian Network Meta-Analysis with Exploratory Evaluation of Retrievable Scaffold Therapy.

Cardiovascular and interventional radiology·2026
Same author

A comparative analysis of echocardiographic data for heart transplant eligibility in brain death cases.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology·2025
Same author

Paclitaxel-Coated Balloon for the Treatment of Small Vessel In-Stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial.

JACC. Cardiovascular interventions·2025
Same author

The potential clinical and public health implications of presymptomatic genetic testing for transthyretin amyloidosis in African American/Black adults in the United States.

Frontiers in genetics·2025
Same author

Prosthetic valve dysfunction post-bevacizumab: a transcatheter aortic valve replacement thrombosis case report.

European heart journal. Case reports·2025

Related Experiment Video

Updated: Feb 17, 2026

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium
05:53

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Published on: March 4, 2016

9.8K

Caught in Time: When IVC Filters Save Lives.

Anwar Zaitoun1, Nikhil Ambulgekar, Andrew Boshara

  • 1St. John Hospital and Medical Center, 22101 Moross Rd, Detroit, MI 48236 USA. anwar.zaitoun@ascension.org.

The Journal of Invasive Cardiology
|December 6, 2017
PubMed
Summary

Inferior vena cava filters prevent life-threatening pulmonary emboli in patients unable to use anticoagulation. This case underscores their critical role in managing extensive deep vein thrombosis.

More Related Videos

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava
06:59

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava

Published on: January 13, 2023

4.6K
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.8K

Related Experiment Videos

Last Updated: Feb 17, 2026

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium
05:53

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Published on: March 4, 2016

9.8K
Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava
06:59

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava

Published on: January 13, 2023

4.6K
Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis
06:03

Electrolytic Inferior Vena Cava Model EIM of Venous Thrombosis

Published on: July 12, 2011

17.8K

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Thrombosis Research

Background:

  • Inferior vena cava filters are crucial for venous thromboembolic disease management when anticoagulation is contraindicated.
  • Extensive proximal deep vein thromboses pose a significant risk of massive pulmonary embolism.

Observation:

  • This case report details the placement of an inferior vena cava filter in a patient with extensive proximal deep vein thromboses.
  • The patient's condition necessitated an alternative to anticoagulation therapy.

Findings:

  • Inferior vena cava filter placement effectively mitigated the risk of pulmonary embolism.
  • The intervention was vital in preventing potentially fatal embolic events.

Implications:

  • Highlights the importance of timely inferior vena cava filter placement in high-risk patients.
  • Emphasizes the role of these filters in preventing sudden cardiac death secondary to massive pulmonary embolism.
  • Supports the use of inferior vena cava filters as a key strategy in managing complex venous thromboembolic disease.